Cargando…
Blockers of the SARS-CoV-2 3a Channel Identified by Targeted Drug Repurposing
The etiological agent of the COVID-19 pandemic is SARS-CoV-2. As a member of the Coronaviridae, the enveloped pathogen has several membrane proteins, of which two, E and 3a, were suggested to function as ion channels. In an effort to increase our treatment options, alongside providing new research t...
Autores principales: | Tomar, Prabhat Pratap Singh, Krugliak, Miriam, Arkin, Isaiah T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004704/ https://www.ncbi.nlm.nih.gov/pubmed/33807095 http://dx.doi.org/10.3390/v13030532 |
Ejemplares similares
-
Identification of SARS-CoV-2 E Channel Blockers from a Repurposed Drug Library
por: Tomar, Prabhat Pratap Singh, et al.
Publicado: (2021) -
Zika M—A Potential Viroporin: Mutational Study and Drug Repurposing
por: Tomar, Prabhat Pratap Singh, et al.
Publicado: (2022) -
SARS-CoV-2 E protein is a potential ion channel that can be inhibited by Gliclazide and Memantine
por: Singh Tomar, Prabhat Pratap, et al.
Publicado: (2020) -
Potential Viroporin Candidates From Pathogenic Viruses Using Bacteria-Based Bioassays
por: Tomar, Prabhat Pratap Singh, et al.
Publicado: (2019) -
Targeting Viral Ion Channels: A Promising Strategy to Curb SARS-CoV-2
por: Singh, Anamika, et al.
Publicado: (2022)